OpenURL Connection Search

Select item for more details and to access through your institution.

hacksig: a unified and tidy R framework to easily compute gene expression signature scores.
Published in:
Bioinformatics, 2022, v. 38, n. 10, p. 2940, doi. 10.1093/bioinformatics/btac161
By:
- Carenzo, Andrea;
- Pistore, Federico;
- Serafini, Mara S;
- Lenoci, Deborah;
- Licata, Armando G;
- Cecco, Loris De
Publication type:
Article
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures.
Published in:
Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00494-5
By:
- Corti, Anna;
- De Cecco, Loris;
- Cavalieri, Stefano;
- Lenoci, Deborah;
- Pistore, Federico;
- Calareso, Giuseppina;
- Mattavelli, Davide;
- de Graaf, Pim;
- Leemans, C. René;
- Brakenhoff, Ruud H.;
- Ravanelli, Marco;
- Poli, Tito;
- Licitra, Lisa;
- Corino, Valentina;
- Mainardi, Luca
Publication type:
Article
Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors.
Published in:
Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1267499
By:
- Minna, Emanuela;
- Devecchi, Andrea;
- Pistore, Federico;
- Paolini, Biagio;
- Mauro, Giuseppe;
- Penso, Donata Alda;
- Pagliardini, Sonia;
- Busico, Adele;
- Pruneri, Giancarlo;
- De Cecco, Loris;
- Borrello, Maria Grazia;
- Sensi, Marialuisa;
- Greco, Angela
Publication type:
Article
Medullary Thyroid Carcinoma Mutational Spectrum Update and Signaling-Type Inference by Transcriptional Profiles: Literature Meta-Analysis and Study of Tumor Samples.
Published in:
Cancers, 2022, v. 14, n. 8, p. 1951, doi. 10.3390/cancers14081951
By:
- Minna, Emanuela;
- Romeo, Paola;
- Dugo, Matteo;
- De Cecco, Loris;
- Aiello, Antonella;
- Pistore, Federico;
- Carenzo, Andrea;
- Greco, Angela;
- Borrello, Maria Grazia
Publication type:
Article
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer.
Published in:
Cells (2073-4409), 2022, v. 11, n. 19, p. 3176, doi. 10.3390/cells11193176
By:
- Cavalieri, Stefano;
- Serafini, Mara Serena;
- Carenzo, Andrea;
- Canevari, Silvana;
- Lenoci, Deborah;
- Pistore, Federico;
- Miceli, Rosalba;
- Vecchio, Stefania;
- Ferrari, Daris;
- Moro, Cecilia;
- Sponghini, Andrea;
- Caldara, Alessia;
- Rocca, Maria Cossu;
- Secondino, Simona;
- Moretti, Gabriella;
- Denaro, Nerina;
- Caponigro, Francesco;
- Vaccher, Emanuela;
- Rinaldi, Gaetana;
- Ferraù, Francesco
Publication type:
Article

Found: 5

hacksig: a unified and tidy R framework to easily compute gene expression signature scores.

MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures.

Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors.

Medullary Thyroid Carcinoma Mutational Spectrum Update and Signaling-Type Inference by Transcriptional Profiles: Literature Meta-Analysis and Study of Tumor Samples.

An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer.